CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Martin Lange

Executive Vice President, R&D and Chief Scientific Officer (CSO), Novo Nordisk

Verified interview transcripts, podcast appearances, and direct quotes from Martin Lange, Executive Vice President, R&D and Chief Scientific Officer (CSO) at Novo Nordisk. AI-verified speaker identity with full-text searchable transcripts.

Recent appearances

  • Novo Nordisk CSO on New Obesity Shot Results and Drug Pipeline

    February 23, 2026 · 📺 Bloomberg Television

    Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company's weight loss obesity shot CagriSema, which delivered less weight loss than Eli Lilly’s tirzepatide. Holst Lange also outlines Novo Nordisk's broader obesity treatment pipeline. He speaks on "Bloomberg Open Interest." -------- More on Bloomberg Television and Markets Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: https://tinyurl.com/ysu5b8a9 Visit http://www.bloomberg.com for business news & analysis, up-…

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →